All terms in MeSH

Label Id Description
phthioceranic acid C522296
centrin3 protein, Trypanosoma brucei brucei C000601660
Biological Coevolution D000073930 [The process of reciprocal evolutionary change occurring between pairs of species or among groups of species as they interact. ]
fasciospongine A C522297
Adverse Outcome Pathways D000073931 [Models connecting initiating events at the cellular and molecular level to population-wide impacts. Computational models may be at levels relating toxicology to adverse effects. ]
fasciospongine B C522298
Food Addiction D000073932 [A cluster of chemical dependencies to specific foods or food in general in which there develops a physical craving for these foods. ]
Narrative Medicine D000073935 [NARRATION as a tool to collect and interpret information on a patient's experience of illness ]
Risk Evaluation and Mitigation D000073938 [Strategies required by the US Food and Drug Administration (FDA) Amendments Act of 2007 when a question exists as to whether the benefits of a drug outweigh its risks. These constitute a safety plan with several potential components, including a medication guide, a communication plan, elements to ensure safe use and an implementation system to help guide the prescribers, pharmacists and patients. ]
NSC13345 C000601669
Dysferlin D000073939 [A membrane protein that contains multiple C2 DOMAINS. It is highly expressed in skeletal muscle and functions as a calcium ion sensor in SYNAPTIC VESICLE-PLASMA MEMBRANE fusion, as well as in SARCOLEMMA repair following mechanical stress. Mutations in the dysferlin (DYSF) gene are associated with several hereditary MUSCULAR DYSTROPHIES. ]
COG8 protein, human C522290
Distal myopathy, Nonaka type C536816
Al-Gazali Syndrome C536817
Giant mammary hamartoma C536818
Melanocytic nevus syndrome, congenital C536819
Chromosome 3, monosomy 3q27 C536810
Chromosome 3, trisomy 3p C536811
Chromosome 3, trisomy 3p25 C536812
Chromosome 3, trisomy 3q C536813